The Discounted Cash Flow (DCF) valuation of Homology Medicines Inc (FIXX) is (2,178.26) USD. With the latest stock price at 24.55 USD, the upside of Homology Medicines Inc based on DCF is -8972.7%.
Based on the latest price of 24.55 USD and our DCF valuation, Homology Medicines Inc (FIXX) is a sell. selling FIXX stocks now will result in a potential gain of 8972.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.2% - 7.4% | 6.3% |
| Long-term Growth Rate | 3.0% - 4.9% | 4.0% |
| Fair Price | (19,657.22) - (1,188.56) | (2,178.26) |
| Upside | -80170.2% - -4941.4% | -8972.7% |